CytoDyn Inc (CYDY)
0.151
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
CytoDyn Shareholders Equity (Quarterly): -119.38M for Feb. 29, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | -119.38M |
November 30, 2023 | -114.38M |
August 31, 2023 | -116.89M |
May 31, 2023 | -109.50M |
February 28, 2023 | -107.01M |
November 30, 2022 | -115.97M |
August 31, 2022 | -94.31M |
May 31, 2022 | -94.40M |
February 28, 2022 | -22.46M |
November 30, 2021 | -12.70M |
August 31, 2021 | -25.19M |
May 31, 2021 | -21.02M |
February 28, 2021 | -15.80M |
November 30, 2020 | -6.534M |
August 31, 2020 | 2.768M |
May 31, 2020 | -2.481M |
February 29, 2020 | -4.383M |
November 30, 2019 | -13.63M |
August 31, 2019 | -6.795M |
May 31, 2019 | -8.914M |
February 28, 2019 | -6.249M |
November 30, 2018 | -8.064M |
August 31, 2018 | -19.80M |
May 31, 2018 | -13.16M |
February 28, 2018 | -7.593M |
Date | Value |
---|---|
November 30, 2017 | -12.79M |
August 31, 2017 | -8.358M |
May 31, 2017 | -1.103M |
February 28, 2017 | 5.417M |
November 30, 2016 | 5.377M |
August 31, 2016 | 6.253M |
May 31, 2016 | 10.21M |
February 29, 2016 | 11.21M |
November 30, 2015 | -2.709M |
August 31, 2015 | -6.714M |
May 31, 2015 | -10.69M |
February 28, 2015 | -3.699M |
November 30, 2014 | -1.689M |
August 31, 2014 | 0.6802M |
May 31, 2014 | 3.922M |
February 28, 2014 | 6.765M |
November 30, 2013 | 9.492M |
August 31, 2013 | -0.4204M |
May 31, 2013 | -0.2239M |
February 28, 2013 | -0.1273M |
November 30, 2012 | 0.2184M |
August 31, 2012 | -4.818M |
May 31, 2012 | -3.973M |
February 29, 2012 | -2.456M |
November 30, 2011 | -6.355M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-119.38M
Minimum
Feb 2024
2.768M
Maximum
Aug 2020
-50.45M
Average
-21.74M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 10.27M |
Total Liabilities (Quarterly) | 129.65M |